NCT02173119View on ClinicalTrials.gov

Can Quantitative MRI After cTACE Help Predict Survival ?

CompletedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

March 7, 2018

Study Completion Date

March 7, 2018

Conditions
Hepatocellular Carcinoma (HCC)
Interventions
OTHER

MRI post-TACE

Perform lipiodol delivery measurements with MRI post-TACE.

Trial Locations (1)

53226

Medical College of Wisconsin/Froedtert Memorial Lutheran Hospital, Milwaukee

Sponsors

Collaborators (1)

Guerbet
All Listed Sponsors
collaborator

Guerbet

INDUSTRY

collaborator

Northwestern University

OTHER

lead

Medical College of Wisconsin

OTHER